Ilia I. Ouspenski

Array ( [id] => 5551795 [patent_doc_number] => 20090285781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => ' Medicament and a method of treating a pathological syndrome' [patent_app_type] => utility [patent_app_number] => 12/495104 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1972 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285781.pdf [firstpage_image] =>[orig_patent_app_number] => 12495104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397334 [patent_doc_number] => 20090317397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Soluble CTLA4 mutant molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/459291 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 22511 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317397.pdf [firstpage_image] =>[orig_patent_app_number] => 12459291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5933319 [patent_doc_number] => 20110041190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'NOVEL CHIMERIC PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/488797 [patent_app_country] => US [patent_app_date] => 2009-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11679 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20110041190.pdf [firstpage_image] =>[orig_patent_app_number] => 12488797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5984617 [patent_doc_number] => 20110097339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Compositions monovalent for CD28 binding and methods of use' [patent_app_type] => utility [patent_app_number] => 12/456703 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 59468 [patent_no_of_claims] => 164 [patent_no_of_ind_claims] => 99 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097339.pdf [firstpage_image] =>[orig_patent_app_number] => 12456703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8102953 [patent_doc_number] => 08153123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Method for restoring dendritic cell populations' [patent_app_type] => utility [patent_app_number] => 12/483159 [patent_app_country] => US [patent_app_date] => 2009-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 9678 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153123.pdf [firstpage_image] =>[orig_patent_app_number] => 12483159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441335 [patent_doc_number] => 20100104559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'US CIP-COMPOSITIONS AND METHODS FOR MODULATING RESPONSES MEDIATED OR ASSOCIATED WITH BTLA ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/482426 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 40183 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104559.pdf [firstpage_image] =>[orig_patent_app_number] => 12482426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601478 [patent_doc_number] => 20100098718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'NUCLEIC ACID VECTORS FOR IMMUNIZATION' [patent_app_type] => utility [patent_app_number] => 12/455444 [patent_app_country] => US [patent_app_date] => 2009-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7578 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098718.pdf [firstpage_image] =>[orig_patent_app_number] => 12455444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223878 [patent_doc_number] => 20100056760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'SIALOADHESIN FACTOR-2 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/474816 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13121 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056760.pdf [firstpage_image] =>[orig_patent_app_number] => 12474816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4484359 [patent_doc_number] => 07902151 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Methods and compositions for modulating immunity' [patent_app_type] => utility [patent_app_number] => 12/470707 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 43 [patent_no_of_words] => 46232 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902151.pdf [firstpage_image] =>[orig_patent_app_number] => 12470707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4618765 [patent_doc_number] => 07998479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Substance specific to human PD-1' [patent_app_type] => utility [patent_app_number] => 12/469188 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 8599 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998479.pdf [firstpage_image] =>[orig_patent_app_number] => 12469188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601345 [patent_doc_number] => 20100098712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Pharmaceutical formulation of an antibody against OX40L' [patent_app_type] => utility [patent_app_number] => 12/454598 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7362 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098712.pdf [firstpage_image] =>[orig_patent_app_number] => 12454598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5315521 [patent_doc_number] => 20090280119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis' [patent_app_type] => utility [patent_app_number] => 12/387359 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26011 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280119.pdf [firstpage_image] =>[orig_patent_app_number] => 12387359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490017 [patent_doc_number] => 20090291088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'THERAPEUTIC COMBINATIONS OF ANTI-IGF-1R ANTIBODIES AND OTHER COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/422045 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 71 [patent_no_of_words] => 129688 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291088.pdf [firstpage_image] =>[orig_patent_app_number] => 12422045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397305 [patent_doc_number] => 20090317368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'B7-H1, A NOVEL IMMUNOREGULATORY MOLECULE' [patent_app_type] => utility [patent_app_number] => 12/421310 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 17582 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317368.pdf [firstpage_image] =>[orig_patent_app_number] => 12421310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33079 [patent_doc_number] => 07785880 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Mammalian cell lines for increasing longevity and protein yield from cell culture' [patent_app_type] => utility [patent_app_number] => 12/405733 [patent_app_country] => US [patent_app_date] => 2009-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18416 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785880.pdf [firstpage_image] =>[orig_patent_app_number] => 12405733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7703150 [patent_doc_number] => 08088905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Nucleic acids encoding antibodies against PD-1' [patent_app_type] => utility [patent_app_number] => 12/405058 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14592 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088905.pdf [firstpage_image] =>[orig_patent_app_number] => 12405058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533066 [patent_doc_number] => 20090232854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'USES OF BISPECIFIC ANTIBODY COATED DENDRITIC CELLS PULSED WITH ANTIGENS AND GM-CSF IN IMMUNE REGULATION' [patent_app_type] => utility [patent_app_number] => 12/401089 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 35523 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232854.pdf [firstpage_image] =>[orig_patent_app_number] => 12401089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134467 [patent_doc_number] => 20110008369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'PD-1 BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/922066 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26201 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008369.pdf [firstpage_image] =>[orig_patent_app_number] => 12922066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580530 [patent_doc_number] => 20090175876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'METHODS OF USING PHHLA2 TO CO-STIMULATE T-CELLS' [patent_app_type] => utility [patent_app_number] => 12/396091 [patent_app_country] => US [patent_app_date] => 2009-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30805 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175876.pdf [firstpage_image] =>[orig_patent_app_number] => 12396091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539667 [patent_doc_number] => 20090221472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Method for treating transplant rejection' [patent_app_type] => utility [patent_app_number] => 12/380063 [patent_app_country] => US [patent_app_date] => 2009-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8309 [patent_no_of_claims] => 109 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221472.pdf [firstpage_image] =>[orig_patent_app_number] => 12380063 [rel_patent_id] =>[rel_patent_doc_number] =>)